Speakers Corner
March 12, 2010
Expected: a massive bailout of banks
A massive bailout of China's major banks might be one of the options to let them recoup much of the 2.4 trillion Renminbi (255 billion euro) spend during the recent financial rescue operation, says professor Victor Shihto BusinessWeek today.
blog link
MacLellan, Douglas
Chairman & CEO at The MacLellan Group
travels from Los Angeles, California, US
Douglas MacLellan has been working in China since 1983 (26 years) and is a recognized authority on joint venture and wholly foreign owned enterprise (WFOE) structuring. Mr. MacLellan is currently Chairman & CEO of AMDL, Inc. a U.S. based Pharma business with significant operations in China. He is also Chairman & CEO of the MacLellan Group an international advisory business focused on China business development. Mr. MacLellan is a senior international business executive, economist, venture capitalist and merchant banker. MacLellan has been a catalyst for the development and financing of global businesses in the United States and throughout the world in countries that include: Bulgaria, Cambodia, Canada, Chile, China, Hungary, India, Korea, Madagascar and Russia over the past 17 years. Throughout his professional career, as a senior international business executive and or as a member of the board of directors of numerous companies, he has provided management, advice and counsel on strategic planning, operational activities, corporate finance, economic policy, asset allocation and mergers & acquisitions. He has helped raise over US$715 million for development stage, start-up and mid-cap companies.
Chairman & CEO at AMDL, Inc
September 1992 - Present In November 2008, Mr. MacLellan became Chairman & CEO of AMDL, Inc. ("AMDL") which is listed on the NYSE Alt under the symbol ("ADL"). From 1992 through October 2008 Mr. MacLellan held various independent positions on the Board of Directors including Chairperson of the Audit & Governance Committee's. The Company is a vertically integrated specialty pharmaceutical company. In combination with its Chinese based subsidiary Jade Pharmaceutical Inc. ("JPI"), the Company engages in the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. (www.amdl.com).
Chairman & CEO at The MacLellan Group
March 1992 - Present MacLellan is Chairman & CEO of the MacLellan Group, Ltd. a seventeen year-old international financial advisory firm (www.maclellangroup.com). Mr. MacLellan is an economist, venture capitalist, merchant banker and business incubation expert. MacLellan has been a catalyst for the development and financing of global businesses in the United States and throughout the world including: Bulgaria, Cambodia, Canada, Chile, China, Hungary, India, Korea, Madagascar and Russia over the past 15 years. Throughout his professional career he has served on the board of numerous companies and has provided advice and counsel on strategic planning, operational activities, corporate finance, economic policy, asset allocation and mergers & acquisitions. He has helped raise over US$715 million for development stage, start-up and mid-cap companies.
Chairman, Co-Founder at Broadband Access MarketSpace, Ltd.
February 2002 - September 2006 Formally, Mr. MacLellan was Chairman of Broadband Access MarketSpace, Ltd. a China-centric IT advisory firm from February 2002 thru September 2006. Broadband Access MarketSpace, Ltd, ("BAM") was a privately held company founded in 2002 to advise on various China-based IT initiatives. BAM owned the "Zinc Networks" brand of VOIP switch, router and modem product lines. The firm specialized in providing cost effective technology solutions to various counties in Latin America.
Vice-Chairman at AXM Pharma, Inc
April 2000 - September 2005 AXM is a publicly listed pharmaceutical company with wholly-owned operations in Shenyang China. AXM has two subsidiaries include AXM Hong Kong which sold branded products in Asia-Pacific and AXM Shenyang which is a manufacturer and distributor of quality over-the-counter, generic and prescription grade drugs and medicines in China.
Co-Founder at Wireless Electronique, Ltd.
March 1998 - June 2001 WelCom was a China based telecommunications company that has participated in the development of three separate GSM cellular based joint ventures in partnership with China Unicom in the provinces of Yunnan, Inner Mongolia and Ningxia China. Approximately US$25 million in equity and debt were invested into WelCom's three joint ventures, where nearly 230,000 cellular customers were developed in the first year of 0perations. There were approximately 68 million gross POP's or 43 million net cash flow POP's in these licensed coverage areas. As part of an industry-wide nationalization, WelCom's joint ventures were reconciled in return for cash and a significant stock allocation in China Unicom's June, 2000 IPO. Upon completion of the reconciliation process in mid- 2001, the Company was wound-up.
Co-Founder & Chairman at Sino-American Medical, Inc
February 1998 - January 2000 Sino-American Medical, Inc. (SAM) was a private company formed for the purpose of developing and financing existing targeted Chinese pharmaceutical product manufacturing and sales companies. SAM's initial operations are located in Jiangxi Province through a Sino-Foreign Equity Joint Venture with Jiangxi Gannan Pharmaceutical Factory ("GANNAN"). Within this joint venture SAM holds a 70 percent interest in Jiangxi Gannan Innovation Pharmaceutical technologies Company, Ltd. ("GIPTECH"). SAM's China based resources include all phases of manufacturing, research, development, clinical trials, sales, marketing and distribution under international GMP standards Due to the Jiangxi Provincial Government's inability to accept a structured financing package, the joint venture was terminated and SAM has closed its operations.
President & CEO at PortaCom Wireless, Ltd.
May 1995 - July 1998 PortaCom Wireless, Inc. was engaged in telecommunications ventures as a developer and operator of companies providing cellular and wireless communications services in selected developing world markets. The Company is developing cellular and wireless telephone networks through joint ventures with a local partners under various telecommunications concessions covering the Chinese, Cambodian, Indian and Vietnamese markets. The Company eliminated its operations in 1999, commenced a liquidation process that included a stock distribution of shares in VDC Corporation (AMEX: VDC) to its shareholders. Mr. MacLellan left PortaCom in March 1998 to pursue multiple China based telecommunications opportunities.
Vice-Chairman at Asian American Telecommunications, Inc.
January 1996 - December 1996 Asian American Telecommunications, Inc. (AAT) now Metromedia China Corporation ("MCC"), a majority owned subsidiary of Metromedia international Group, Inc. is a China based telecommunications company with four joint ventures in the province of Sichuan, Chongching City and Ningbo City (with China Unicom) and holds interests in several e-commerce operations. The Company invested approximately US$125 million in its joint venture operations. As part of an industry-wide nationalization, MCC's four joint ventures were reconciled in return for cash from ChinaUnicom. The Company has redirected its business operations to focus exclusively on China based e-commerce businesses. Mr. MacLellan left the Board upon the completion of the merger with MCC.
travels from Los Angeles, California, US
Douglas MacLellan has been working in China since 1983 (26 years) and is a recognized authority on joint venture and wholly foreign owned enterprise (WFOE) structuring. Mr. MacLellan is currently Chairman & CEO of AMDL, Inc. a U.S. based Pharma business with significant operations in China. He is also Chairman & CEO of the MacLellan Group an international advisory business focused on China business development. Mr. MacLellan is a senior international business executive, economist, venture capitalist and merchant banker. MacLellan has been a catalyst for the development and financing of global businesses in the United States and throughout the world in countries that include: Bulgaria, Cambodia, Canada, Chile, China, Hungary, India, Korea, Madagascar and Russia over the past 17 years. Throughout his professional career, as a senior international business executive and or as a member of the board of directors of numerous companies, he has provided management, advice and counsel on strategic planning, operational activities, corporate finance, economic policy, asset allocation and mergers & acquisitions. He has helped raise over US$715 million for development stage, start-up and mid-cap companies.
Chairman & CEO at AMDL, Inc
September 1992 - Present In November 2008, Mr. MacLellan became Chairman & CEO of AMDL, Inc. ("AMDL") which is listed on the NYSE Alt under the symbol ("ADL"). From 1992 through October 2008 Mr. MacLellan held various independent positions on the Board of Directors including Chairperson of the Audit & Governance Committee's. The Company is a vertically integrated specialty pharmaceutical company. In combination with its Chinese based subsidiary Jade Pharmaceutical Inc. ("JPI"), the Company engages in the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. (www.amdl.com).
Chairman & CEO at The MacLellan Group
March 1992 - Present MacLellan is Chairman & CEO of the MacLellan Group, Ltd. a seventeen year-old international financial advisory firm (www.maclellangroup.com). Mr. MacLellan is an economist, venture capitalist, merchant banker and business incubation expert. MacLellan has been a catalyst for the development and financing of global businesses in the United States and throughout the world including: Bulgaria, Cambodia, Canada, Chile, China, Hungary, India, Korea, Madagascar and Russia over the past 15 years. Throughout his professional career he has served on the board of numerous companies and has provided advice and counsel on strategic planning, operational activities, corporate finance, economic policy, asset allocation and mergers & acquisitions. He has helped raise over US$715 million for development stage, start-up and mid-cap companies.
Chairman, Co-Founder at Broadband Access MarketSpace, Ltd.
February 2002 - September 2006 Formally, Mr. MacLellan was Chairman of Broadband Access MarketSpace, Ltd. a China-centric IT advisory firm from February 2002 thru September 2006. Broadband Access MarketSpace, Ltd, ("BAM") was a privately held company founded in 2002 to advise on various China-based IT initiatives. BAM owned the "Zinc Networks" brand of VOIP switch, router and modem product lines. The firm specialized in providing cost effective technology solutions to various counties in Latin America.
Vice-Chairman at AXM Pharma, Inc
April 2000 - September 2005 AXM is a publicly listed pharmaceutical company with wholly-owned operations in Shenyang China. AXM has two subsidiaries include AXM Hong Kong which sold branded products in Asia-Pacific and AXM Shenyang which is a manufacturer and distributor of quality over-the-counter, generic and prescription grade drugs and medicines in China.
Co-Founder at Wireless Electronique, Ltd.
March 1998 - June 2001 WelCom was a China based telecommunications company that has participated in the development of three separate GSM cellular based joint ventures in partnership with China Unicom in the provinces of Yunnan, Inner Mongolia and Ningxia China. Approximately US$25 million in equity and debt were invested into WelCom's three joint ventures, where nearly 230,000 cellular customers were developed in the first year of 0perations. There were approximately 68 million gross POP's or 43 million net cash flow POP's in these licensed coverage areas. As part of an industry-wide nationalization, WelCom's joint ventures were reconciled in return for cash and a significant stock allocation in China Unicom's June, 2000 IPO. Upon completion of the reconciliation process in mid- 2001, the Company was wound-up.
Co-Founder & Chairman at Sino-American Medical, Inc
February 1998 - January 2000 Sino-American Medical, Inc. (SAM) was a private company formed for the purpose of developing and financing existing targeted Chinese pharmaceutical product manufacturing and sales companies. SAM's initial operations are located in Jiangxi Province through a Sino-Foreign Equity Joint Venture with Jiangxi Gannan Pharmaceutical Factory ("GANNAN"). Within this joint venture SAM holds a 70 percent interest in Jiangxi Gannan Innovation Pharmaceutical technologies Company, Ltd. ("GIPTECH"). SAM's China based resources include all phases of manufacturing, research, development, clinical trials, sales, marketing and distribution under international GMP standards Due to the Jiangxi Provincial Government's inability to accept a structured financing package, the joint venture was terminated and SAM has closed its operations.
President & CEO at PortaCom Wireless, Ltd.
May 1995 - July 1998 PortaCom Wireless, Inc. was engaged in telecommunications ventures as a developer and operator of companies providing cellular and wireless communications services in selected developing world markets. The Company is developing cellular and wireless telephone networks through joint ventures with a local partners under various telecommunications concessions covering the Chinese, Cambodian, Indian and Vietnamese markets. The Company eliminated its operations in 1999, commenced a liquidation process that included a stock distribution of shares in VDC Corporation (AMEX: VDC) to its shareholders. Mr. MacLellan left PortaCom in March 1998 to pursue multiple China based telecommunications opportunities.
Vice-Chairman at Asian American Telecommunications, Inc.
January 1996 - December 1996 Asian American Telecommunications, Inc. (AAT) now Metromedia China Corporation ("MCC"), a majority owned subsidiary of Metromedia international Group, Inc. is a China based telecommunications company with four joint ventures in the province of Sichuan, Chongching City and Ningbo City (with China Unicom) and holds interests in several e-commerce operations. The Company invested approximately US$125 million in its joint venture operations. As part of an industry-wide nationalization, MCC's four joint ventures were reconciled in return for cash from ChinaUnicom. The Company has redirected its business operations to focus exclusively on China based e-commerce businesses. Mr. MacLellan left the Board upon the completion of the merger with MCC.
